Stock Events

Stock Events

Xilio Therapeutics (XLO) Q1 2025 Earnings

11MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.62

-0.45

-0.28

-0.11

Details

Expected EPS

-0.2167

Actual EPS

-0.2

Surprise EPS

0.02

Surprise Percent

+7.71%

Description

Xilio Therapeutics (XLO) has reported earnings of -0.2 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.